Using recombinant human epidermal growth factor for the successful treatment of an excisional wound without a primary closure.
Department of Dermatology, College of Medicine, Kyung Hee University, Seoul, Korea.
Dong Woo
DW
Suh
Bark Lynn
BL
Lew
Woo Young
WY
Sim
D000279:Administration, Cutaneous; D000368:Aged; D004431:Ear, External / Q000187:drug effects / Q000473:pathology / Q000601:surgery; D004815:Epidermal Growth Factor / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007636:Keratoacanthoma / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D008297:Male; D062326:Re-Epithelialization / Q000187:drug effects; D011994:Recombinant Proteins / Q000627:therapeutic use; D013997:Time Factors; D016896:Treatment Outcome; D014945:Wound Healing / Q000187:drug effects*
D011994:Recombinant Proteins; D004815:Epidermal Growth Factor